Comparative Study of the Efficacy of Olmesartan/Amlodipine vs. Perindopril/Amlodipine in Peripheral and Central Blood Pressure Parameters After Missed Dose in Type 2 Diabetes-Reference-Cited by-同舟云学术

Comparative Study of the Efficacy of Olmesartan/Amlodipine vs. Perindopril/Amlodipine in Peripheral and Central Blood Pressure Parameters After Missed Dose in Type 2 Diabetes

Published:2016-05-24 Issue:9 Volume:29 Page:1055-1062
ISSN:0895-7061
Container-title:American Journal of Hypertension
language:en
Short-container-title:AJHYPE

Author:

Redon Josep,Pichler Gernot

Publisher

Oxford University Press (OUP)

Subject

Internal Medicine

Link

http://academic.oup.com/ajh/article-pdf/29/9/1055/17047111/hpw033.pdf

Reference45 articles.

1. Central Blood Pressure as an Index of Antihypertensive Control: Determinants and Potential Value

2. Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension

3. Estimation of central aortic blood pressure

4. Pulse wave velocity and the non-invasive methods used to assess it: Complior, SphygmoCor, Arteriograph and Vicorder

5. Carotid-femoral pulse wave velocity assessment by two different methods: implications for risk assessment;Pichler;J Hypertens,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial;Cardiovascular Diabetology;2021-01-04

2. What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics;European Journal of Clinical Pharmacology;2020-09-29

3. Effects of Angiotensin-Converting Enzyme Inhibitors on Arterial Stiffness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Cardiovascular Therapeutics;2020-03-01

4. Central blood pressure for the management of hypertension: Is it a practical clinical tool in current practice?;The Journal of Clinical Hypertension;2019-12-16

5. Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan;Advances in Therapy;2018-12-27